ZORYVE
ZORYVE
Approved
DIN Number
02552566
Drug Class
Human
Market Date
Oct 22, 2024
Company
HC
arcutis canada, inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02552566
AIG Number0152826002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX06 ROFLUMILAST
Product Specifications
Dosage FormFoam
Route of AdministrationTopical
AHFS Classification48:32.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROFLUMILASTActive
Strength: 0.3 % / W/W
Monograph: ROFLUMILAST